Biotechnological production of lipid and terpenoid from thraustochytrids

Fei Du,Yu-Zhou Wang,Ying-Shuang Xu,Tian-Qiong Shi,Wen-Zheng Liu,Xiao-Man Sun,He Huang
DOI: https://doi.org/10.1016/j.biotechadv.2021.107725
IF: 17.681
2021-05-01
Biotechnology Advances
Abstract:<p>As fungus-like protists, thraustochytrids have been increasingly studied for their faster growth rates and high lipid content. In the 1990s, thraustochytrids were used as docosahexaenoic acid (DHA) producers for the first time. Thraustochytrids genera, such as <em>Thraustochytrium</em>, <em>Schizochytrium</em>, and <em>Aurantiochytrium</em> have been developed and patented as industrial strains for DHA production. The high DHA yield is attributed to its unique and efficient polyketide-like synthase (PKS) pathway. Moreover, thraustochytrids possess a completed mevalonate (MVA) pathway, so it can be used as host for terpenoid production. In order to improve strain performance, the metabolic engineering strategies have been applied to promote or disrupt intracellular metabolic pathways, such as genetic engineering and addition of chemical activators. However, it is difficult to realize industrialization only by improving strain performance. Various operation strategies were developed to enlarge the production quantities from the laboratory-scale, including two-stage cultivation strategies, scale-up technologies and bioreactor design. Moreover, an economical and effective downstream process is also an important consideration for the industrial application of thraustochytrids. Downstream costs accounts for 20–60% of the overall process costs, which represents an attractive target for increasing the cost-competitiveness of thraustochytrids, including how to improve the efficiency of lipid extraction and the further application of biomass residues. This review aims to overview the whole lipid biotechnology of thraustochytrids to provide the background information for researchers.</p>
biotechnology & applied microbiology
What problem does this paper attempt to address?
The paper aims to address the issues of producing lipids and terpenoids through biotechnology, specifically using thraustochytrids as a production platform. Specifically, the paper focuses on the following aspects: 1. **High-yield lipid and DHA production**: Thraustochytrids have garnered attention for their rapid growth and high lipid content, especially since they were first used to produce docosahexaenoic acid (DHA) in the 1990s. The paper discusses how to improve strain performance through metabolic engineering strategies to increase the yield of DHA and other lipids. 2. **Production of terpenoids**: Thraustochytrids possess a complete mevalonate (MVA) pathway, making them suitable hosts for terpenoid production. The paper explores how to enhance the yield of terpenoids through metabolic and genetic engineering methods. 3. **Technical challenges of industrial production**: Improving strain performance alone is insufficient for industrial production. The paper introduces various operational strategies, such as two-stage cultivation strategies, scale-up techniques, and bioreactor design, to increase production from laboratory scale. 4. **Cost optimization of downstream processing**: Downstream processing costs account for 20% to 60% of the total process cost. Therefore, improving lipid extraction efficiency and further application of biomass residues are important considerations for industrial applications. In summary, the main issue the paper attempts to address is improving the efficiency and economic viability of thraustochytrids in the production of lipids and terpenoids through biotechnological means to meet market demand.